In a statement, Wegovy's maker Novo Nordisk said it was "encouraged" by the new guidance from CMS but said it hopes to see Part D coverage expanded for "obesity medicines when used for chronic weight management." The drug maker is among those pushing for Congress to expand coverage of treatments for obesity
Combining Copper Peptides with Other Hair Loss Treatments Copper peptides fit cleanly into a stacked protocol because they address biological dimensions that other treatments don't
Better Metabolic Health: Retatrutide not only helps with weight loss, but also improves overall metabolic function, reducing risks related to heart health
Leg Cramps: Why They Strike at Night, When to Worry, and When to Seek Medical Help | Leg cramps, which can occur suddenly at night, are painful and can upset ones daily routine
Mochi patients may achieve similar clinical benefits if medications are prescribed at appropriate doses and combined with lifestyle modification
Read All